fda indications for glp 1 Advised to Update Labels on GLP-1 Weight-Loss Drugs GLP-1 Receptor Agonists: A Guide

doi:10.1097/RHU.0000000000001949 8

Be sure to stay well hydrated while on GLP-1 medications

Long-term safety data in humans are nonexistent for this specific blend

Obes Surg 35(3):11271134 Esparham A et al (2024) Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: a systematic review and meta-analysis

Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World [PMID: 38776037] Laboratory literature summary: Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023